The effect of the infusion connection point on intravenous multi-infusion drug delivery to premature neonates – Use of standard concentration infusions of critical medications

IF 4.4 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Kamelia Krysiak , Naomi McCallion , Brian Cleary , Fiona O’Brien
{"title":"The effect of the infusion connection point on intravenous multi-infusion drug delivery to premature neonates – Use of standard concentration infusions of critical medications","authors":"Kamelia Krysiak ,&nbsp;Naomi McCallion ,&nbsp;Brian Cleary ,&nbsp;Fiona O’Brien","doi":"10.1016/j.ejpb.2024.114391","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Sick neonates with haemodynamic instability often require complex medication regimens, which may result in the connection of a catecholamine infusion distally. This increases the dead volume of the infusion system, extending the time to medication delivery. This study evaluated the effects of body weight, and infusion connection point on the delivery rate of two medications infused through a multi-infusion system at infusion rates suitable for extremely and very low birth weight (ELBW and VLBW) neonates.</p></div><div><h3>Methods</h3><p>An infusion system consisting of six infusions was used to investigate time to delivery, drug concentration at time to delivery and quantity of adrenaline and dopamine administered by intravenous infusions at infusion rates suitable for premature neonates.</p></div><div><h3>Results</h3><p>In an ELBW neonate model, the measured adrenaline and dopamine concentration at <span><math><mfrac><mn>1</mn><mn>2</mn></mfrac></math></span> T was higher than expected (66.7 (7.5)% (mean (SD)) and 68.0 (4.4)%, respectively, <em>P</em> &lt; 0.001). At the calculated time to delivery, neither drug reached target concentration. In a VLBW neonate model, the measured adrenaline and dopamine concentration at <span><math><mfrac><mn>1</mn><mn>2</mn></mfrac></math></span> T was higher than expected (92.2 (7.1)% and 97.1 (3.1)%, respectively, <em>P</em> &lt; 0.001). Adrenaline reached target concentration at 27 (11) min and dopamine at 56 (12) min, times significantly shorter than calculated.</p><p>The measured quantity of adrenaline and dopamine delivered was lower (<em>P</em> &lt; 0.001) than calculated in all tested combinations except adrenaline at proximal connection (97.2 (3.4)%, <em>P</em> = 0.097) in the VLBW neonate model.</p></div><div><h3>Conclusions</h3><p>Using the most proximal available infusion connection considerably improves drug delivery times and drug doses delivered, which is critical during the administration of short-acting cardiovascular medications.</p></div>","PeriodicalId":12024,"journal":{"name":"European Journal of Pharmaceutics and Biopharmaceutics","volume":null,"pages":null},"PeriodicalIF":4.4000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0939641124002170/pdfft?md5=6d826280a3a91ac528006f2b101d756c&pid=1-s2.0-S0939641124002170-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutics and Biopharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0939641124002170","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Sick neonates with haemodynamic instability often require complex medication regimens, which may result in the connection of a catecholamine infusion distally. This increases the dead volume of the infusion system, extending the time to medication delivery. This study evaluated the effects of body weight, and infusion connection point on the delivery rate of two medications infused through a multi-infusion system at infusion rates suitable for extremely and very low birth weight (ELBW and VLBW) neonates.

Methods

An infusion system consisting of six infusions was used to investigate time to delivery, drug concentration at time to delivery and quantity of adrenaline and dopamine administered by intravenous infusions at infusion rates suitable for premature neonates.

Results

In an ELBW neonate model, the measured adrenaline and dopamine concentration at 12 T was higher than expected (66.7 (7.5)% (mean (SD)) and 68.0 (4.4)%, respectively, P < 0.001). At the calculated time to delivery, neither drug reached target concentration. In a VLBW neonate model, the measured adrenaline and dopamine concentration at 12 T was higher than expected (92.2 (7.1)% and 97.1 (3.1)%, respectively, P < 0.001). Adrenaline reached target concentration at 27 (11) min and dopamine at 56 (12) min, times significantly shorter than calculated.

The measured quantity of adrenaline and dopamine delivered was lower (P < 0.001) than calculated in all tested combinations except adrenaline at proximal connection (97.2 (3.4)%, P = 0.097) in the VLBW neonate model.

Conclusions

Using the most proximal available infusion connection considerably improves drug delivery times and drug doses delivered, which is critical during the administration of short-acting cardiovascular medications.

Abstract Image

输液连接点对早产新生儿静脉多次输液给药的影响 - 使用标准浓度输注关键药物。
背景:血流动力学不稳定的患病新生儿通常需要复杂的药物治疗方案,这可能导致儿茶酚胺输注的远端连接。这会增加输液系统的死体积,延长给药时间。本研究评估了体重和输液连接点对通过多输液系统以适合极低和超低出生体重(ELBW 和 VLBW)新生儿的输液速度输注两种药物的输液速度的影响:方法:使用一个由六次输液组成的输液系统,以适合早产新生儿的输液速度研究肾上腺素和多巴胺的输液时间、输液时间的药物浓度和输液量:结果:在 ELBW 新生儿模型中,12 T 时测得的肾上腺素和多巴胺浓度高于预期(分别为 66.7 (7.5) %(平均值(标清))和 68.0 (4.4) %,P<0.05)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.80
自引率
4.10%
发文量
211
审稿时长
36 days
期刊介绍: The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics. Topics covered include for example: Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids) Aspects of manufacturing process design Biomedical aspects of drug product design Strategies and formulations for controlled drug transport across biological barriers Physicochemical aspects of drug product development Novel excipients for drug product design Drug delivery and controlled release systems for systemic and local applications Nanomaterials for therapeutic and diagnostic purposes Advanced therapy medicinal products Medical devices supporting a distinct pharmacological effect.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信